Th2 cytokine mRNA expression in primary cutaneous CD30-positive lymphoproliferative disorders: Successful treatment with recombinant interferon-γ

Journal of Investigative Dermatology

Volumn 107, Issue 6, 1996, Pages 827-832

  Yagi, Hiroaki ^a   Tokura, Yoshiki ^a   Furukawa, Fukumi ^a   Takigawa, Masahiro ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Anaplastic large cell lymphoma; Cutaneous T cell lymphoma; Ki 1+ lymphoma; Lymphomatoid papulosis

Indexed keywords

BIOGAMMA; CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; MESSENGER RNA; RECOMBINANT GAMMA INTERFERON; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; FEMALE; HUMAN; INTRADERMAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LARGE CELL LYMPHOMA; LYMPHOMATOID PAPULOSIS; LYMPHOPROLIFERATIVE DISEASE; MALE; PRIORITY JOURNAL; SKIN LYMPHOMA;

EID: 0029855951     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1111/1523-1747.ep12330845     Document Type: Article

References (46)

1. Banerjee SS, Heald J, Harris M: Twelve cases of Ki-1 positive anaplastic large cell lymphoma of the skin. J Clin Pathol 44:119-125, 1991
2. Beljaards RC, Kaudewitz P, Berti E, Gianotti R, Neumann C, Rosso R, Paulli M, Meijer CJLM, Willemze R: Primary cutaneous CD30-positive large cell lymphoma: definition of a new type of cutaneous lymphoma with a favorable prognosis: an European multicenter study on 47 patients. Cancer 71:2097-2104, 1993
3. Beljaards RC, Meijer CJLM, Scheffer E, Toonstra J, van Vloten WA, van der Putte SCJ, Geerts ML, Willemze R: Prognostic significance of CD30 (Ki-1/Ber-H2) expression in primary cutaneous large-cell lymphomas of T-cell origin: a clinicopathologic and immunohistochemical study in 20 patients. Am J Pathol 135:1169-1178, 1989
4. Beljaards RC, Willemze R: The prognosis of patients with lymphomatoid papulosis associated with malignant lymphomas. Br J Dermatol 126:596-602, 1992
5. Boguniewicz M, Jaffe HS, Izu A, Sullivan MJ, York D, Geha RS, Leung DY: Recombinant gamma interferon in treatment of patients with atopic dermatitis and elevated IgE levels. Am J Med 88:365-370, 1990
6. Borish L, Dishuck J, Cox L, Mascali JJ, Williams J, Rosenwasser LJ: Sezary syndrome with elevated serum IgE and hypereosinophilia: role of dysregulated cytokine production. J Allergy Clin Immunol 92:123-131, 1993
7. Bos JD, Zonneveld I, Doss PK, Kreig ST, Vanderloos CTM, Kapsenherg ML: The skin immune system: distribution and immunophenotype of lymphocyte subpopulations in normal human skin. J Invest Dermatol 88:569-573, 1987
8. Brinkmann V, Geiger T, Alkan S, Heusser CH: Interferon alpha increases the frequency of interferon gamma producing human CD4 T cells. J Exp Med 178:1655-1663, 1993
9. Chan JKC, Ng CS, Hui PK, Leung TW, Lo ES, Lau WH, McGuire LJ: Anaplastic large cell Ki-1 lymphoma: delineation of two morphological types. Histopathology 15:11-34, 1989
10. Chan SH, Perussia B, Gupta JW, Kobayashi M, Pospisil M, Young HA, Wolf SF, Young D, Clark SC, Trinchieri G: Induction of IFN-γ production by NK cell stimulatory factor (NKSF): characterization of the responder cells and synergy with other inducers. J Exp Med 173:869-879, 1991
11. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159, 1987
12. Clerici M, Hakim FT, Venzon DJ, Blatt S, Hendrix CW, Wynn TA, Shearer GM: Changes in interleukin-2 and interleukin-4 production in asymptomatic, human immunodeficiency virus-seropositive individuals. J Clin Invest 91:759-765, 1993
13. Curco N, Servitje O, Sais G, Moreno A, Peyri J: Primary cutaneous CD30-positive large-cell lymphoma: a case with fatal outcome. J Am Acad Dermatol 31:1068-1069, 1994
14. Davis TH, Morton CC, Miller-Cassman R, Balk SP, Kadin ME: Hodgkin's disease, lymphomatoid papulosis, and cutaneous T-cell lymphoma derived from a common T-cell clone. N Engl J Med 326:1115-1122, 1992
15. de Bruin PC, Beljaards RC, van Heerde P, Van Der Valk P, Noorduyn LA, Van Krieken JHJM, Kluin-Nelemans JC, Willemze R, Meijer CJLM: Differences in clinical behaviour and immunophenotype between primary cutaneous and primary nodal anaplastic large cell lymphoma of T-cell or null cell phenotype. Histopathology 23:127-135, 1993
16. + lymphoproliferative disorders: comparison with anaplastic large-cell lymphoma of nodal origin. Blood 87:3437-3441, 1996
17. + T cells producing Th2-type cytokines. FASEB J 9:81-86, 1995
18. Enk AH, Katz SI: Identification and induction of keratinocyte-derived IL-10. J Immunol 149:92-95, 1992
19. Fushimi M, Tokura Y, Sachi Y, Hashizume H, Sudo H, Wakita H, Furukawa F, Takigawa M: Eosinophilic pustular folliculitis effectively treated with recombinant interferon-γ: suppression of mRNA expression of interleukin 5 in peripheral blood mononuclear cells. Br J Dermatol 134:766-772, 1996
20. Ikuta K, Ogura T, Shimizu A, Honjo T: Low frequency of somatic mutation in β-chain variable region genes of human T-cell receptors. Proc Natl Acad Sci USA 82: 7701-7705, 1985
21. Kadin ME: Common activated helper-T-cell origin for lymphomatoid papulosis, mycosis fungoides, and some types of Hodgkin's disease. Lancet II:864-865, 1985
22. + cutaneous lymphomas. Curr Probl Dermatol 19:132-143, 1990
23. Kadin ME, Nasu K, Sako D, Vonderheid EC: Lymphomatoid papulosis: a cutaneous proliferation of activated helper T cells expressing Hodgkin's disease-associated antigens. Am J Pathol 119:315-325, 1985
24. Kaplan EH, Rosen ST, Norris DB, Roenigk HH, Saks SR, Bunn PA: Phase II study of recombinant human interferon γ for treatment of cutaneous T-cell lymphoma. J Natl Cancer Inst 82:208-212, 1990
25. + suppressor cells of autoimmune encephalomyelitis respond to T cell receptor-associated determinants on effector cells by interleukin-4 secretion. Eur J Immunol 22:1757-1763, 1992
26. +) anaplastic large cell lymphomas: morphologic, immunohistologic, and clinical characteristics. Am J Pathol 135:359-367, 1989
27. Macaulay WL: Lymphomatoid papulosis: a continuing self-healing eruption, clinically benign - histologically malignant. Arch Dermatol 97:23-30, 1968
28. + T cell clones in human immunodeficiency virus infection. J Exp Med 180:2407-2411, 1994
29. Mosmann TR, Coffman RL: TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 7:145-173, 1989
30. Olsen EA, Rosen ST, Vollmer RT, Variakojis D, Roenigk HH, Diab N, Zeffren J: Interferon alpha-2a in the treatment of cutaneous T-cell lymphoma. J Am Acad Dermatol 20:395-407, 1989
31. Parks JD, Synovec MS, Masih AS, Braddock SW, Nakamine H, Sanger WG, Harrington DS, Weisenburger DD: Immunophenotypic and genotypic characterization of lymphomatoid papulosis. J Am Acad Dermatol 26:968-975, 1992
32. Paul WE, Seder RA: Lymphocyte responses and cytokines. Cell 76:241-251, 1994
33. Rapoport MJ, Jaramillo A, Zipris D, Lazarus AH, Serreze DV, Leiter EH, Cyopic P, Danska JS, Delovitch TL: Interleukin 4 reverses T cell proliferative responsiveness and prevents the onset of diabetes in nonobese diabetic mice. J Exp Med 178:87-99, 1993
34. Romagnani S: Human Th1 and Tb2 subsets: doubt no more. Immunol Today 12:256-257, 1991
35. Rook AH, Kubin M, Cassin M, Vonderheid EC, Vowels BR, Wolfe JT, Wolf SF, Singh A, Trinchieri G, Lessin SR: IL-12 reverses cytokine and immune abnormalities in Sezary syndrome. J Immunol 154:1491-1498, 1995
36. Saed G, Fivenson DP, Naidu Y, Nickoloff J: Mycosis fungoides exhibits a Th1-type cell-mediated cytokine profile whereas Sezary syndrome expresses a Th2-type profile. J Invest Dermatol 103:29-33, 1994
37. Saiki RK, Gelfand DH, Stoffel S, Scharf SJ, Higuchi R, Horn GT, Mullis KB, Erlich HA: Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 239:487-491, 1988
38. Sypek JP, Chung CL, Mayor SEH, Subramanyam JM, Goldman SJ, Sieburth DS, Wolf SF, Schaub RG: Resolution of cutaneous leishmaniasis: interleukin-12 initiates a protective T helper type 1 immune response. J Exp Med 177:1797-1802, 1993
39. Tendler CL, Burton JD, Jaffe J, Danielpour D, Charley M, McCoy JP, Pittelkow MR, Waldmann TA: Abnormal cytokine expression in Sezary and adult T-cell leukemia cells correlates with the functional diversity between these T-cell malignancies. Cancer Res 54:4430-4435, 1994
40. Tokura Y, Takigawa M, Oku T, Yamada M: Lymphomatoid papulosis. Histologic and immunohistochemical studies in a patient with a scaly pigmented eruption. Arch Dermatol 122:1400-1405, 1986
41. Vowels BR, Cassin M, Vonderheid EC, Rook AH: Aberrant cytokine production by Sezary syndrome patients: cytokine secretion pattern resembles murine Th2 cells. J Invest Dermatol 99:90-94, 1992
42. Vowels BR, Lessin SR, Cassin M, Jaworsky C, Benoit B, Wolfe JT, Rook AH: Th2 cytokine mRNA expression in skin in cutaneous T-cell lymphoma. J Invest Dermatol 103:669-673, 1994
43. Willemze R: New concepts in the classification of cutaneous lymphomas. Arch Dermatol 131:1077-1080, 1995
44. Willemze R, Beljaards RC: Spectrum of primary cutaneous CD30 (Ki-1)-positive lymphoproliferative disorders. J Am Acad Dermatol 28:973-980, 1993
45. Willemze R, Scheffer E, Ruiter DJ, van Vloten WA, Meijer CJLM: Immunological, cytochemical and ultrastructural studies in lymphomatoid papulosis. Br J Dermatol 108:381-394, 1983
46. Yagi H, Tokura Y, Furukawa F, Takigawa M: CD7-positive Sezary syndrome with a Th1 cytokine profile. J Am Acad Dermatol 34:368-374, 1996